ロード中...
The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study
BACKGROUND: HCV transmission remains high in people who inject drugs (PWID) in Montréal. New direct-acting antivirals (DAAs), highly effective and more tolerable than previous regimens, make a “Treatment as Prevention” (TasP) strategy more feasible. This study assesses how improvements in the cascad...
保存先:
| 出版年: | BMC Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5320702/ https://ncbi.nlm.nih.gov/pubmed/28222681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2256-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|